{"id":928816,"date":"2026-01-20T16:03:18","date_gmt":"2026-01-20T21:03:18","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\/"},"modified":"2026-01-20T16:03:18","modified_gmt":"2026-01-20T21:03:18","slug":"vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\/","title":{"rendered":"Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th"},"content":{"rendered":"<p>        <!--body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th<\/b><\/p>\n<p>BOSTON&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.vrtx.com&amp;esheet=54400169&amp;newsitemid=20260120813466&amp;lan=en-US&amp;anchor=Vertex+Pharmaceuticals+Incorporated&amp;index=1&amp;md5=5c361d0af6a381cf14e95081825adf63\">Vertex Pharmaceuticals Incorporated<\/a> (Nasdaq: VRTX) will report its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and reference the \u201cVertex Pharmaceuticals Fourth Quarter 2025 Earnings Call.\u201d<\/p>\n<p>\nThe conference call will be webcast live and a link to the webcast can be accessed through Vertex&#8217;s website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.vrtx.com%2F&amp;esheet=54400169&amp;newsitemid=20260120813466&amp;lan=en-US&amp;anchor=www.vrtx.com&amp;index=2&amp;md5=c52074854c38c0587746ccc1323e05ac\">www.vrtx.com<\/a> in the \u201cInvestors\u201d section. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An archived webcast will be available on the company&#8217;s website.<\/p>\n<p><b>About Vertex<\/b><\/p>\n<p>\nVertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and conditions. The company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, primary membranous nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes and myotonic dystrophy type 1.<\/p>\n<p>\nVertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia, Latin America and the Middle East. Vertex is consistently recognized as one of the industry&#8217;s top places to work, including 16 consecutive years on Science magazine&#8217;s Top Employers list and one of Fortune\u2019s 100 Best Companies to Work For. For company updates and to learn more about Vertex&#8217;s history of innovation, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.vrtx.com%2F&amp;esheet=54400169&amp;newsitemid=20260120813466&amp;lan=en-US&amp;anchor=www.vrtx.com&amp;index=3&amp;md5=ecdea4ae8b5e1e19bc0bf88a3d0bdcc4\">www.vrtx.com<\/a> or follow us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fvertex-pharmaceuticals%2F&amp;esheet=54400169&amp;newsitemid=20260120813466&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=4&amp;md5=755ea1de2551c41b6b244c22a04f79e5\">LinkedIn<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FVertexPharmaInc&amp;esheet=54400169&amp;newsitemid=20260120813466&amp;lan=en-US&amp;anchor=Facebook&amp;index=5&amp;md5=993a4ca6d7e65aef619716575349ca0c\">Facebook<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fvertexpharmaceuticals%2F&amp;esheet=54400169&amp;newsitemid=20260120813466&amp;lan=en-US&amp;anchor=Instagram&amp;index=6&amp;md5=ecee34c2882372350118d7426663690e\">Instagram<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2F%40Vertex-Pharmaceuticals&amp;esheet=54400169&amp;newsitemid=20260120813466&amp;lan=en-US&amp;anchor=YouTube&amp;index=7&amp;md5=9e1ee3303b5f16576bfd0520e529f666\">YouTube<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fx.com%2FVertexPharma&amp;esheet=54400169&amp;newsitemid=20260120813466&amp;lan=en-US&amp;anchor=X&amp;index=8&amp;md5=37824555d4a4c9fb0e35a06cf1423cac\">X<\/a>.<\/p>\n<p>\n(VRTX-WEB)<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260120813466r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260120813466\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260120813466\/en\/<\/a><\/span><\/p>\n<p><b>Vertex Pharmaceuticals Incorporated Investor Relations:<br \/>\n<\/b><br \/><a rel=\"nofollow\" href=\"mailto:investorinfo@vrtx.com\">investorinfo@vrtx.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Massachusetts United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Research Medical Devices Diabetes Clinical Trials Health Technology Biotechnology Health Pharmaceutical Science<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260120813466\/en\/1093022\/3\/Vertex_Logo_colorRGB.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th BOSTON&#8211;(BUSINESS WIRE)&#8211;Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and reference the \u201cVertex Pharmaceuticals Fourth Quarter 2025 Earnings Call.\u201d The conference call will be webcast live and a link to the webcast can be accessed through Vertex&#8217;s website at www.vrtx.com in the \u201cInvestors\u201d section. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-928816","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th BOSTON&#8211;(BUSINESS WIRE)&#8211;Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and reference the \u201cVertex Pharmaceuticals Fourth Quarter 2025 Earnings Call.\u201d The conference call will be webcast live and a link to the webcast can be accessed through Vertex&#8217;s website at www.vrtx.com in the \u201cInvestors\u201d section. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to &hellip; Continue reading &quot;Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-20T21:03:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260120813466r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th\",\"datePublished\":\"2026-01-20T21:03:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\\\/\"},\"wordCount\":386,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260120813466r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\\\/\",\"name\":\"Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260120813466r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-01-20T21:03:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260120813466r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260120813466r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\/","og_locale":"en_US","og_type":"article","og_title":"Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th - Market Newsdesk","og_description":"Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th BOSTON&#8211;(BUSINESS WIRE)&#8211;Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and reference the \u201cVertex Pharmaceuticals Fourth Quarter 2025 Earnings Call.\u201d The conference call will be webcast live and a link to the webcast can be accessed through Vertex&#8217;s website at www.vrtx.com in the \u201cInvestors\u201d section. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to &hellip; Continue reading \"Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\/","og_site_name":"Market Newsdesk","article_published_time":"2026-01-20T21:03:18+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260120813466r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th","datePublished":"2026-01-20T21:03:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\/"},"wordCount":386,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260120813466r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\/","name":"Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260120813466r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-01-20T21:03:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260120813466r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260120813466r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vertex-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-february-12th\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/928816","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=928816"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/928816\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=928816"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=928816"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=928816"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}